Author:
Morena Jonathan,Gupta Anirudh,Hoyle J. Chad
Abstract
Charcot-Marie-Tooth (CMT) is the most prevalent category of inherited neuropathy. The most common inheritance pattern is autosomal dominant, though there also are X-linked and autosomal recessive subtypes. In addition to a variety of inheritance patterns, there are a myriad of genes associated with CMT, reflecting the heterogeneity of this disorder. Next generation sequencing (NGS) has expanded and simplified the diagnostic yield of genes/molecules underlying and/or associated with CMT, which is of paramount importance in providing a substrate for current and future targeted disease-modifying treatment options. Considerable research attention for disease-modifying therapy has been geared towards the most commonly encountered genetic mutations (PMP22, GJB1, MPZ, and MFN2). In this review, we highlight the clinical background, molecular understanding, and therapeutic investigations of these CMT subtypes, while also discussing therapeutic research pertinent to the remaining less common CMT subtypes.
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference123 articles.
1. Recent advances in the genetic neuropathies
2. Neuropathy;Pisciotta;Handb. Clin. Neurol.,2018
3. Epidemiologic Study of Charcot-Marie-Tooth Disease: A Systematic Review
4. Genetic epidemiology of Charcot-Marie-Tooth in the general population
5. Prevalence and origin of de novo duplications in charcot-marie-tooth disease type 1a: First report of a de novo duplication with a maternal origin;Blair;Am. J. Hum. Genet.,1996
Cited by
103 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献